CT
OPRX icon

Colonial Trust’s OptimizeRx OPRX Stock Holding History

Colonial Trust’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-512
Closed -$2.7K – 1267
2024
Q4 		$2.7K Buy
512
+121
+31% +$676 ﹤0.01% 1178
2024
Q3 		$3.03K Buy
391
+70
+22% +$622 ﹤0.01% 957
2024
Q2 		$3.31K Buy
321
+61
+23% +$670 ﹤0.01% 892
2024
Q1 		$3.16K Hold
260
– – ﹤0.01% 881
2023
Q4 		$3.77K Buy
260
+122
+88% +$1.17K ﹤0.01% 828
2023
Q3 		$1.12K Sell
138
-77
-36% -$838 ﹤0.01% 928
2023
Q2 		$3.06K Hold
215
– – ﹤0.01% 846
2023
Q1 		$3.12K Hold
215
– – ﹤0.01% 807
2022
Q4 		$3.56K Buy
+215
New +$3.72K ﹤0.01% 796

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Colonial Trust's OPRX Position: Q1 2025 in Review

Colonial Trust sold out of OptimizeRx (OPRX) in Q1 2025, closing a stake of 512 shares — an estimated $2.7K sold.

Colonial Trust first reported a position in OPRX in Q4 2022 and held it in 9 quarters. The position peaked at $3.77K in Q4 2023. 87 funds tracked by Wall St. Rank hold OPRX as of Q1 2025.

  • Colonial Trust reported no remaining OptimizeRx position as of Q1 2025 after selling out during the quarter.
  • Colonial Trust sold 512 OptimizeRx shares in Q1 2025, an estimated $2.7K.
  • Colonial Trust first reported a position in OptimizeRx in Q4 2022 and held it in 9 quarters.
  • Colonial Trust's OptimizeRx position peaked at $3.77K in Q4 2023.
  • 87 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2025.

Based on Colonial Trust's 13F filing for Q1 2025, filed 14 May 2025.